After-Market Losers: Gap (NYSE:GPS), YuMe (NYSE:YUME), Acadia Pharmaceuticals (NASDAQ:ACAD), Ross Stores Inc. (NASDAQ:ROST)

gap

The Gap (NYSE:GPS) reported Q4 earnings and revenue that were mixed. The Gap net income for the 13 weeks ended February 1, 2014 was $307 million, or $0.68 per share on a diluted basis. This compares with net income of $351 million, or $0.73 per share on a diluted basis, for the 14 weeks ended February 2, 2013. The Gap reported revenue of $4.57 billion, down from $4.73 billion a year prior.

The Street expected income of $0.66 per share on revenue of $4.6 billion, according to Capital IQ estimates. The company expects earnings per share to be in the range of $2.90 to $2.95 for fiscal year 2014, which is below the Street view of $3.04. Gap will increase the company’s annual dividend to $0.88 in fiscal year 2014, a 10% increase from the company’s current annualized rate of $0.80. This represents more than a 75% increase in the company’s annual dividend per share in the last two years.

YuMe (NYSE:YUME) says Q4 sales were $54 million, up 19% from a year ago but below the Thomson Reuters mean for $59.51 million. Net income was $0.16 per share, a penny ahead of estimates. It sees Q1 sales between $35.0 million – $36.0 million and 2014 sales between $190 million – $200 million.

Acadia Pharmaceuticals (NASDAQ:ACAD) reported a net income loss of $12.0 million, or $(0.13) per share for Q4 2013, beating the estimate for a loss of $0.14. Revenue of $37,000 missed estimates of $310,000 and were down 90% from the same quarter last year. Shares of ACAD are down 2% in after-hours trading with a 52-week range of $5.86 to $31.45.

Ross Stores Inc. (NASDAQ:ROST) fell 3.2% in late trading after the company provided Q1 guidance that was below analyst estimates. The store chain estimated Q1 earnings would rise 4% to 7% from a year earlier to a range of $1.11 to $1.15 a share, compared with the Capital IQ estimate of $1.20. Ross said Q4 earnings were $1.02 a share for a 13-week sales period, matching the Capital IQ estimate of $1.02. The company posted earnings of $1.07 a year ago during a 14-week sales period.

Q4 revenue was $2.74 billion, compared with the consensus estimate of $2.7 billion. Comparable store sales rose 2% from a year earlier. Wedbush Securities Inc. began coverage of Ross this morning with an Outperform rating and a price target of $83. The stock declined 3.2% to a $70.01 a share. It reached a 52-week high of $81.99 on November 18.

 

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone